A global healthcare & communications agency, in Switzerland's Health Valley

BUSINESS WIN FEB-rin, first reproductive microbiome modulator

Helvet Health is proud to collaborate with FERRING for the launch of FEB-rin®, a specially formulated intravaginal ovule that significantly increases Lactobacilli presence during ovarian stimulation, influencing the vaginal microbiome towards a healthier bacterial state. FERRING is leading the innovation in the reproductive microbiome and fertility. Helvet Health is contributing in the creation of all strategic, medical, and creative campaign elements.